JavaScript Required

Jumpseat Aerospace News requires JavaScript to function. Please enable JavaScript in your browser settings to continue.

Shyld AI Secures $13.4M for Agentic AI in Healthcare

May 14, 2026

2 min read

Key Takeaways

Shyld AI raises $13.4M in seed funding led by Aulis Capital.
The company develops Agentic AI for autonomous disinfection in hospitals.
System combines AI with UV-C light, reducing contamination by 93%.
Shyld AI plans to expand into pharmaceutical manufacturing and cleanrooms.

Silver membership required Upgrade to Silver to access Key Takeaways.

Upgrade

Strategic Implications

Shyld AI's funding may indicate growing interest in Active Intelligence for healthcare, suggesting a shift towards more autonomous and proactive solutions. This could signal a new direction for the industry, potentially leading to improved patient outcomes and reduced operational burdens on healthcare staff.

Silver membership required Upgrade to Silver to access Strategic Implications.

Upgrade

What Happened

Autonomous Disinfection Technology Expands Across US Health Systems

Shyld AI has secured $13.4 million in seed funding to scale its Agentic AI and autonomous disinfection technology across US health systems. The company’s flagship system combines AI with UV-C light to reduce contamination by over 93%, according to a Stanford University study. Shyld AI plans to expand its technology into pharmaceutical manufacturing and regulated cleanrooms, with the goal of ensuring strict compliance and safety standards are met autonomously. This development was reported by HIT Consultant.

Source

Companies Mentioned